SST and Parkinson disease: Decreased CSF somatostatin, decreased somatostatin immuno-reactivity, and binding sites are also observed in the temporal cortex and frontal cortex of patients with Parkinson’s disease (Beal et al., 1986; Epelbaum et al., 1988).